Toggle light / dark theme

Meta delays return to office to an optimistic March 28

Why they need to return office?đŸ€”đŸ€”.Can’t they work from virtual world?


Meta, the company that at the beginning of this pandemic was called Facebook, has updated its return-to-office guidance, moving its target date from the end of this month to March 28, CNBC reports. With the shifting timetables for reopening and inconsistent guidance, one can only imagine how whiplashed the company’s employees must feel.

To wit: Back in December of 2020, CEO Mark Zuckerberg first told employees they would not be required to receive a COVID-19 vaccine in order to return to work. At that time, the company projected remote work could continue until at least July of 2021, though it later pushed to open offices in May. By June, Zuckerberg had passed a new edict: either seek permission from a manager to work from home, or be expected to come to the office for at least half the week.

A month later the Delta variant came along, Zuckerberg changed his stance on vaccine requirements for employees, and the company set a new target of October for a full reopening. By August of last year, it had pushed its the return-to-office to January of 2022. As Omicron spread rapidly this winter, Meta held fast to its January 31 goal, but gave some employees the option to delay in-person work by three to five months via an “office deferral program.” Incidentally, this new March 28 date includes a new requirement that employees receive the vaccine booster as well.

Newcomer Conduit Leverages Frontera to Understand SARS-CoV-2 ‘Budding’

I am happy to say that my recently published computational COVID-19 research has been featured in a major news article by HPCwire! I led this research as CTO of Conduit. My team utilized one of the world’s top supercomputers (Frontera) to study the mechanisms by which the coronavirus’s M proteins and E proteins facilitate budding, an understudied part of the SARS-CoV-2 life cycle. Our results may provide the foundation for new ways of designing antiviral treatments which interfere with budding. Thank you to Ryan Robinson (Conduit’s CEO) and my computational team: Ankush Singhal, Shafat M., David Hill, Jr., Tamer Elkholy, Kayode Ezike, and Ricky Williams.


Conduit, created by MIT graduate (and current CEO) Ryan Robinson, was founded in 2017. But it might not have been until a few years later, when the pandemic started, that Conduit may have found its true calling. While Conduit €™s commercial division is busy developing a Covid-19 test called nanoSPLASH, its nonprofit arm was granted access to one of the most powerful supercomputers in the world €”Frontera, at the Texas Advanced Computing Center (TACC) €”to model the €œbudding € process of SARS-CoV-2.

Budding, the researchers explained, is how the virus €™ genetic material is encapsulated in a spherical envelope €”and the process is key to the virus €™ ability to infect. Despite that, they say, it has hitherto been poorly understood:

The Conduit team €”comprised of Logan Thrasher Collins (CTO of Conduit), Tamer Elkholy, Shafat Mubin, David Hill, Ricky Williams, Kayode Ezike and Ankush Singhal €”sought to change that, applying for an allocation from the White House-led Covid-19 High-Performance Computing Consortium to model the budding process on a supercomputer.

Dr Anthony Atala, MD — Director, Wake Forest Inst for Regenerative Medicine — Printing Human Tissues

Bio-Printing Complex Human Tissues & Organs — Dr. Anthony Atala, MD — Director, Wake Forest Institute for Regenerative Medicine, Wake Forest School of Medicine, Wake Forest University.


Dr. Anthony Atala, MD, (https://school.wakehealth.edu/Faculty/A/Anthony-Atala) is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine, and the W. Boyce Professor and Chair of Urology.

A practicing surgeon and a researcher in the area of regenerative medicine, fifteen applications of technologies developed Dr. Atala’s laboratory have been used clinically. He is Editor of 25 books and 3 journals, has published over 800 journal articles, and has received over 250 national and international patents. Dr. Atala was elected to the Institute of Medicine of the National Academies of Sciences, to the National Academy of Inventors as a Charter Fellow, and to the American Institute for Medical and Biological Engineering.

Dr. Atala is a recipient of the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently working on a discovery that will significantly affect society; the World Technology Award in Health and Medicine, for achieving significant and lasting progress; the Edison Science/Medical Award for innovation, the R&D Innovator of the Year Award, and the Smithsonian Ingenuity Award for Bioprinting Tissue and Organs. Dr. Atala’s work was listed twice as Time Magazine’s Top 10 medical breakthroughs of the year, and once as one of 5 discoveries that will change the future of organ transplants. He was named by Scientific American as one of the world’s most influential people in biotechnology, by U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century, by Life Sciences Intellectual Property Review as one of the top key influencers in the life sciences intellectual property arena, and by Nature Biotechnology as one of the top 10 translational researchers in the world.

Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. He is a founding member of the Tissue Engineering Society, Regenerative Medicine Foundation, Regenerative Medicine Manufacturing Innovation Consortium, Regenerative Medicine Development Organization, and Regenerative Medicine Manufacturing Society.

Transhumanism (Full Documentary)

TABLE OF CONTENTS —————
0:00–21:02 : Introduction (Meaning of Life)
21:03–46:14 CHAPTER 1: Transhumanism and Life Extension.

TWITTER https://twitter.com/Transhumanian.
PATREON https://www.patreon.com/transhumania.
BITCOIN 14ZMLNppEdZCN4bu8FB1BwDaxbWteQKs8i.
ETHEREUM 0x1f89b261562C8D4C14aA01590EB42b2378572164
LITECOIN LdB94n8sTUXBto5ZKt82YhEsEmxomFGz3j.

#1 ) THE GENETIC PATHWAY

46:15–58:52 CHAPTER 2 : Biological Aging a. “Programmed Cell Death” Theory of Aging b. “Intercellular Competition” Theory of Aging c. “Antagonistic Pleiotropy” Theory of Aging.

#2 ) THE CYBERNETIC PATHWAY

58:53–1:12:26 CHAPTER 3 : Cyborgs.

Genflow to become Europe’s first longevity biotech IPO

The company is developing novel therapeutics targeting aging in humans and dogs by using genetically modified adeno-associated virus (AAV) vectors to deliver copies of the SIRT6 gene variant found in centenarians. SIRT6 has already been shown to have significant capabilities to repair DNA damage, and Genflow’s aim is to show that it can also improve healthspan and, potentially, increase lifespan. “Our business model is to develop our lead compound, GF-1002, that has already yielded encouraging pre-clinical results,” Leire told us. “We are currently undertaking pre-clinical trials which are expected to take approximately two years.


SIRT6 targeting longevity biotech announces intention to float on the London Stock Exchange, with IPO later this month.

Swedish lab eyes poisoned chalice in malaria fight

Cages meshed over with women’s tights and crawling with mosquitoes are stashed in a Swedish laboratory. Every day, researchers feed them beetroot juice laced with deadly toxins, part of a grand plan designed to fight malaria.

With hopes of field trials delayed repeatedly by the COVID-19 pandemic, researchers in Sweden still believe they have found the secret to a new environmentally friendly way of killing off the Anopheles species of mosquitoes that transmit .

So hopeful are they, they have founded a company with a view to turning their discovery into a commercially viable alternative to the pesticides currently used to kill mosquitoes, but which can also harm humans and the environment.

Cypriot Scientist Says Deltacron Covid Variant Isn’t Error

A Cypriot scientist defended his assertion that a new strain of Covid-19 exists that combines characteristics of the delta and omicron variants.

Other scientists have speculated that Leonidos Kostrikis’s findings are a result of laboratory contamination. But he told Bloomberg in an emailed statement Sunday that the cases he has identified “indicate an evolutionary pressure to an ancestral strain to acquire these mutations and not a result of a single recombination event.”

‘Dark genome’ offers insight into bipolar and schizophrenia

đ™€đ™«đ™€đ™Ąđ™Șđ™©đ™žđ™€đ™Łđ™–đ™§đ™ź đ™—đ™žđ™€đ™Ąđ™€đ™œđ™žđ™šđ™©đ™š đ™đ™–đ™«đ™š đ™©đ™§đ™€đ™Ș𝙗𝙡𝙚 đ™šđ™­đ™„đ™Ąđ™–đ™žđ™Łđ™žđ™Łđ™œ 𝙬𝙝𝙼 đ™šđ™˜đ™đ™žđ™Żđ™€đ™„đ™đ™§đ™šđ™Łđ™žđ™– 𝙖𝙣𝙙 đ™—đ™žđ™„đ™€đ™Ąđ™–đ™§ đ™™đ™žđ™šđ™€đ™§đ™™đ™šđ™§ — 𝙬𝙝𝙞𝙘𝙝 𝙖𝙧𝙚 𝙝𝙞𝙜𝙝𝙡𝙼 đ™đ™šđ™§đ™žđ™©đ™–đ™—đ™Ąđ™š đ™˜đ™€đ™Łđ™™đ™žđ™©đ™žđ™€đ™Łđ™š — đ™„đ™šđ™§đ™šđ™žđ™šđ™© 𝙞𝙣 đ™„đ™€đ™„đ™Șđ™Ąđ™–đ™©đ™žđ™€đ™Łđ™š đ™™đ™šđ™šđ™„đ™žđ™©đ™š 𝙝𝙖𝙧𝙱𝙞𝙣𝙜 đ™§đ™šđ™„đ™§đ™€đ™™đ™Șđ™˜đ™©đ™žđ™«đ™š đ™›đ™žđ™©đ™Łđ™šđ™šđ™š.

𝙍𝙚𝙹𝙚𝙖𝙧𝙘𝙝𝙚𝙧𝙹 𝙱𝙖𝙼 đ™đ™–đ™«đ™š đ™›đ™€đ™Ș𝙣𝙙 𝙖𝙣 đ™šđ™­đ™„đ™Ąđ™–đ™Łđ™–đ™©đ™žđ™€đ™Ł 𝙞𝙣 đ™§đ™šđ™˜đ™šđ™Łđ™©đ™Ąđ™ź đ™šđ™«đ™€đ™Ąđ™«đ™šđ™™ đ™§đ™šđ™œđ™žđ™€đ™Łđ™š đ™€đ™› đ™©đ™đ™š 𝙝đ™Ș𝙱𝙖𝙣 đ™œđ™šđ™Łđ™€đ™ąđ™š đ™©đ™đ™–đ™© 𝙖𝙧𝙚 đ™Łđ™€đ™© đ™Ș𝙹đ™Ș𝙖𝙡𝙡𝙼 đ™§đ™šđ™˜đ™€đ™œđ™Łđ™žđ™Żđ™šđ™™ 𝙖𝙹 𝙜𝙚𝙣𝙚𝙹 𝙗đ™Șđ™© 𝙘𝙖𝙣 đ™šđ™©đ™žđ™Ąđ™Ą đ™˜đ™€đ™™đ™š đ™›đ™€đ™§ đ™„đ™§đ™€đ™©đ™šđ™žđ™Łđ™š.

𝙏𝙝𝙞𝙹 “𝙙𝙖𝙧𝙠 đ™œđ™šđ™Łđ™€đ™ąđ™šâ€ 𝙱𝙖𝙼 đ™œđ™šđ™Łđ™šđ™§đ™–đ™©đ™š đ™„đ™§đ™€đ™©đ™šđ™žđ™Łđ™š đ™©đ™đ™–đ™© 𝙖𝙧𝙚 đ™«đ™žđ™©đ™–â€Š See more.

The Neuro-Network.

đ‚đ„đźđžđŹ 𝐭𝐹 đšđ«đąđ đąđ§đŹ 𝐹𝐟 đ›đąđ©đšđ„đšđ« 𝐚𝐧𝐝 đŹđœđĄđąđłđšđ©đĄđ«đžđ§đąđš 𝐟𝐹𝐼𝐧𝐝 𝐱𝐧 â€˜đđšđ«đ€ 𝐠𝐞𝐧𝐹𝐩𝐞’


The authors of a recent study on the genetics of schizophrenia and bipolar disorder identify a potential role for the so-called dark genome.